Cargando…

Multidimensional complexities of filariasis control in an era of large-scale mass drug administration programmes: a can of worms

The impact of control and elimination programmes by mass drug administration (MDA) targeting onchocerciasis and lymphatic filariasis (LF) in sub-Saharan Africa over the last two decades has resulted in significantly reduced prevalence and intensity of infection, with some areas interrupting transmis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Molyneux, David H, Hopkins, Adrian, Bradley, Mark H, Kelly-Hope, Louise A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261528/ https://www.ncbi.nlm.nih.gov/pubmed/25128408 http://dx.doi.org/10.1186/1756-3305-7-363

Ejemplares similares

Can malaria vector control accelerate the interruption of lymphatic filariasis transmission in Africa; capturing a window of opportunity?
por: Kelly-Hope, Louise A, et al.
Publicado: (2013)

Quantifying conflict zones as a challenge to certification of Guinea worm eradication in Africa: a new analytical approach
por: Kelly-Hope, Louise A, et al.
Publicado: (2021)

Elimination of Lymphatic Filariasis in The Gambia
por: Rebollo, Maria P., et al.
Publicado: (2015)

Lymphatic filariasis in the Democratic Republic of Congo; micro-stratification overlap mapping (MOM) as a prerequisite for control and surveillance
por: Kelly-Hope, Louise A, et al.
Publicado: (2011)

Increasing evidence of low lymphatic filariasis prevalence in high risk Loa loa areas in Central and West Africa: a literature review
por: Kelly-Hope, Louise A., et al.
Publicado: (2018)

The Health and Economic Burdens of Lymphatic Filariasis Prior to Mass Drug Administration Programs
por: Mathew, Christopher G, et al.
Publicado: (2020)

Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria
por: Pam, Dung D., et al.
Publicado: (2017)

African regional progress and status of the programme to eliminate lymphatic filariasis: 2000–2020
por: Deribe, Kebede, et al.
Publicado: (2020)

Loa loa vectors Chrysops spp.: perspectives on research, distribution, bionomics, and implications for elimination of lymphatic filariasis and onchocerciasis
por: Kelly-Hope, Louise, et al.
Publicado: (2017)

Subcutaneous filariasis: An unusual presentation with an adult gravid worm on aspiration
por: Nanda, Annu, et al.
Publicado: (2018)

Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis - a rapid assessment methodology to assess impact
por: Mohammed, Khalfan A, et al.
Publicado: (2012)

Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011
por: Graves, Patricia M, et al.
Publicado: (2013)

National Mass Drug Administration Costs for Lymphatic Filariasis Elimination
por: Goldman, Ann S., et al.
Publicado: (2007)

No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds
por: Coulibaly, Yaya Ibrahim, et al.
Publicado: (2022)

Elimination of lymphatic filariasis: current perspectives on mass drug administration
por: Gyapong, John O, et al.
Publicado: (2018)

Impact of mass drug administration for elimination of lymphatic filariasis in Nepal
por: Ojha, Chet Raj, et al.
Publicado: (2017)

Correction to: No evidence of lymphatic filariasis transmission in Bamako urban setting after three mass drug administration rounds
por: Coulibaly, Yaya Ibrahim, et al.
Publicado: (2022)

Mapping and modelling the impact of mass drug adminstration on filariasis prevalence in Myanmar
por: Aye, Ni Ni, et al.
Publicado: (2018)

Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection
por: Khan, Abdul Mabood
Publicado: (2018)

The burden of mental health in lymphatic filariasis
por: Ton, Thanh G.N., et al.
Publicado: (2015)

Lymphatic Filariasis in Nigeria; Micro-stratification Overlap Mapping (MOM) as a Prerequisite for Cost-Effective Resource Utilization in Control and Surveillance
por: Okorie, Patricia N., et al.
Publicado: (2013)

Sustained reduction in prevalence of lymphatic filariasis infection in spite of missed rounds of mass drug administration in an area under mosquito nets for malaria control
por: Njenga, Sammy M, et al.
Publicado: (2011)

How community engagement strategies shape participation in mass drug administration programmes for lymphatic filariasis: The case of Luangwa District, Zambia
por: Silumbwe, Adam, et al.
Publicado: (2019)

Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia
por: Bhullar, Navneet, et al.
Publicado: (2010)

Factors determining noncompliance to mass drug administration for lymphatic filariasis elimination
por: Nujum, Zinia T, et al.
Publicado: (2012)

Integrated risk mapping and landscape characterisation of lymphatic filariasis and loiasis in South West Nigeria
por: Brant, Tara A., et al.
Publicado: (2017)

Comparison of Staging Systems to Assess Lymphedema Caused by Cancer Therapies, Lymphatic Filariasis, and Podoconiosis
por: Douglass, Janet, et al.
Publicado: (2019)

Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka
por: Weerasooriya, Mirani V, et al.
Publicado: (2007)

Diversity and transmission competence in lymphatic filariasis vectors in West Africa, and the implications for accelerated elimination of Anopheles-transmitted filariasis
por: de Souza, Dziedzom K, et al.
Publicado: (2012)

Tackling worms in children: school programmes can work – for eyes too
por: Addiss, David
Publicado: (2013)

Reduction in Acute Filariasis Morbidity during a Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea
por: Tisch, Daniel J., et al.
Publicado: (2011)

Qualitative analysis of the impact of a lymphatic filariasis elimination programme using mass drug administration on Misima Island, Papua New Guinea
por: Wynd, Shona, et al.
Publicado: (2007)

Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators
por: Jambulingam, Purushothaman, et al.
Publicado: (2016)

Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA)
por: Collyer, Benjamin S., et al.
Publicado: (2020)

Cessation of Mass Drug Administration for Lymphatic Filariasis in Zanzibar in 2006: Was Transmission Interrupted?
por: Rebollo, Maria P., et al.
Publicado: (2015)

Evaluation of mass drug administration in the program to control imported lymphatic filariasis in Thailand
por: Toothong, Tanaporn, et al.
Publicado: (2015)

Community views on mass drug administration for filariasis: a qualitative evidence synthesis
por: Taylor, Melissa, et al.
Publicado: (2022)

Factors Associated with the Acceptability of Mass Drug Administration for Filariasis: A Systematic Review
por: Abdul Halim, Ahmad Farid Nazmi, et al.
Publicado: (2022)

Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis
por: Alshehri, Abdullah, et al.
Publicado: (2023)

The geographical distribution of lymphatic filariasis infection in Malawi
por: Ngwira, Bagrey MM, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_mdecg774u3bfaqbtfpttsspebr